Rivaroxaban for the Treatment of Symptomatic Isolated Distal Deep Vein Thrombosis
Phase of Trial: Phase III
Latest Information Update: 08 May 2017
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Deep vein thrombosis
- Focus Therapeutic Use
- Acronyms RIDTS
- 01 May 2017 Planned End Date changed from 1 Jun 2020 to 1 Jun 2021.
- 01 May 2017 Planned primary completion date changed from 1 Jun 2018 to 1 Jun 2019.
- 01 May 2017 Status changed from not yet recruiting to recruiting.